News & Events

StageBio Announces New Vice President, Commercial: Lecia Johnson

StageBio, a leading international provider of GLP-compliant research, preclinical and clinical histopathology and biospecimen archiving services for life sciences industry, announces that Ms. Lecia Johnson has been appointed to Vice President, Commercial of StageBio.

As Vice President, Commercial, and a part of the StageBio leadership team, Lecia will support the company’s mission by:

  • Offering an innovative and collaborative approach with clients to meet their goals
  • Overseeing StageBio’s commercial organization and strategy
  • Fostering a cohesive, thriving work environment within the commercial team
  • Providing key insight and strategies to maintain continued organic growth
  • Supporting executive leadership on strategic decision making

We are thrilled and proud that Lecia Johnson is joining the StageBio team. Lecia’s dedication to drug development intertwined with her vast sales management expertise in the CRO and life science industries will strengthen our team and equip us for a brighter future. We look forward to her contributions to StageBio.” – Lori Ball, CEO.

Prior to joining StageBio, Ms. Johnson served as Executive Director of Sales for Covance by Labcorp, where she was responsible for creating an Inside Sales organization (or function) and leading that team to success while providing a mutually beneficial partnership with clients.

Ms. Johnson brings nearly three decades of experience in the life science field, including 15+ years in the contract research organization field, where her sales leadership and strategic growth initiatives led business development teams to success. She is committed to the success and development of her sales team, evidenced by her success in global integration of her sales teams and history of sales training and mentoring.

Ms. Johnson’s passion for ongoing drug development and how it benefits people makes her a great fit for the StageBio mission.

StageBio is committed to our mission of improving lives through high-quality histopathology, diagnostics and research. Join us in welcoming Lecia Johnson as part of this mission and StageBio team!

About StageBio

StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries. The company operates four GLP laboratories as well as three GLP specimen archiving facilities in the U.S., along with one GLP laboratory in Europe. We will continue to make investments in facility and technology infrastructure to meet the growing demand for high-quality histopathology services globally. StageBio has a team of 25+ board-certified veterinary pathologists and more than 100 laboratory technicians on staff supporting our unified commitment to quality, scientific integrity and client satisfaction. Learn more at

Back to Index

Learn more about StageBio’s COVID-19 response